Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart’s Top Stock Pick. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Medifast Inc (MED)

Medifast Inc (MED)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,223,658
  • Shares Outstanding, K 11,018
  • Annual Sales, $ 1,526 M
  • Annual Income, $ 164,030 K
  • 60-Month Beta 1.22
  • Price/Sales 0.78
  • Price/Cash Flow 7.36
  • Price/Book 9.22
Trade MED with:

Options Overview Details

View History
  • Implied Volatility 57.05% ( -3.29%)
  • Historical Volatility 39.86%
  • IV Percentile 79%
  • IV Rank 63.26%
  • IV High 68.84% on 02/23/22
  • IV Low 36.74% on 11/15/21
  • Put/Call Vol Ratio 0.57
  • Today's Volume 11
  • Volume Avg (30-Day) 115
  • Put/Call OI Ratio 1.04
  • Today's Open Interest 2,184
  • Open Int (30-Day) 2,611

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate 1.85
  • Number of Estimates 2
  • High Estimate 1.91
  • Low Estimate 1.79
  • Prior Year 3.56
  • Growth Rate Est. (year over year) -48.03%

Price Performance

See More
Period Period Low Period High Performance
1-Month
107.00 +8.82%
on 09/29/22
129.91 -10.37%
on 09/12/22
-2.61 (-2.19%)
since 09/02/22
3-Month
107.00 +8.82%
on 09/29/22
188.93 -38.37%
on 07/06/22
-67.73 (-36.78%)
since 07/01/22
52-Week
107.00 +8.82%
on 09/29/22
235.71 -50.60%
on 11/08/21
-71.88 (-38.17%)
since 10/04/21

Most Recent Stories

More News
Medifast Launches Free Nationwide K-5 Curriculum Promoting Healthy Habits

/PRNewswire/ -- Medifast (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, announced today the...

MED : 115.44 (+3.94%)
Medifast Announces Quarterly Dividend

/PRNewswire/ -- Medifast (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, announced today that its...

MED : 115.44 (+3.94%)
Medifast: Why I’m Buying This Top Stock on the Dip

Obesity rates have skyrocketed in the United States over the last several decades. The COVID-19 pandemic ...

MED : 115.44 (+3.94%)
Medifast (MED) Down More Than 20% in 3 Months on Cost Woes

Medifast (MED) has been seeing high SG&A expenses and escalated raw material costs. The company expects short-term margin pressure in 2022 due to inflation and continued investments.

GIS : 78.01 (-0.60%)
CHEF : 31.32 (+6.21%)
MED : 115.44 (+3.94%)
CELH : 93.30 (+2.28%)
Are Options Traders Betting on a Big Move in Medifast (MED) Stock?

Investors need to pay close attention to Medifast (MED) stock based on the movements in the options market lately.

MED : 115.44 (+3.94%)
Medifast (MED) Q2 Earnings Top Estimates, Guidance Lowered

Medifast's (MED) second-quarter 2022 results reflect increased active earning OPTAVIA Coaches and elevated costs. Management cuts guidance for 2022 due to inflation.

GIS : 78.01 (-0.60%)
SYY : 74.66 (+3.56%)
CHEF : 31.32 (+6.21%)
MED : 115.44 (+3.94%)
Medifast (MED) Surpasses Q2 Earnings Estimates

Medifast (MED) delivered earnings and revenue surprises of 17.99% and 2%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

MED : 115.44 (+3.94%)
NOMD : 14.51 (+1.68%)
Zacks.com featured highlights include UFP Industries, MEDIFAST, Skyline, Hudson Global and Expeditors International of Washington

UFP Industries, MEDIFAST, Skyline, Hudson Global and Expeditors International of Washington are part of Zacks Screen of the Week article.

EXPD : 91.85 (+1.03%)
HSON : 34.89 (+0.40%)
SKY : 59.37 (+6.36%)
MED : 115.44 (+3.94%)
Medifast (MED) Readies for Q2 Earnings: What's in the Cards?

Medifast's (MED) second-quarter 2022 results are likely to reflect gains from its OPTAVIA lifestyle solution and coaching support system, while escalated costs might have been a concern.

TSN : 67.29 (+0.85%)
K : 71.66 (+0.83%)
MED : 115.44 (+3.94%)
CTVA : 60.96 (+3.01%)
Explore DuPont Analysis & Pick 5 Top Stocks

Do you have more faith in DuPont analysis than simple ROE calculation? Tap UFP Industries (UFPI), MEDIFAST (MED), Skyline (SKY), Hudson Global (HSON) and Expeditors International of Washington (EXPD)....

UFPI : 76.70 (+2.69%)
EXPD : 91.85 (+1.03%)
HSON : 34.89 (+0.40%)
SKY : 59.37 (+6.36%)
MED : 115.44 (+3.94%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Medifast is a leading manufacturer and distributor of clinically-proven healthy living products and programs. The company produces, distributes and sells weight loss, weight management and healthy living products throughits direct online channels as well as franchise weight control centers. The company...

See More

Key Turning Points

3rd Resistance Point 117.09
2nd Resistance Point 114.52
1st Resistance Point 112.79
Last Price 115.44
1st Support Level 108.50
2nd Support Level 105.93
3rd Support Level 104.20

See More

52-Week High 235.71
Fibonacci 61.8% 186.54
Fibonacci 50% 171.36
Fibonacci 38.2% 156.17
Last Price 115.44
52-Week Low 107.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar